High-dose radiotherapy in patients with high-risk prostate cancers treated with long-term androgen deprivation therapy (GETUG AFU 18): a randomised, phase 3 trial

Lectura recomendada por el  Dr. Leandro Recagni. 

Conferencia 2026: «Tratamientos no invasivos del cáncer de próstata a través de la radioterapia»

• Autores: Christophe Hennequin; Paul Sargos; Lise Roca; Marion Silva; Igor Latorzeff; Didier Peiffert; Salvatore Cozzi; Ahmed Benyoucef; Ali Hasbini, et al.
• Fuente: The Lancet Oncology. 2026;27:1158–1167.
• Link: High-dose radiotherapy in patients with high-risk prostate cancers treated with long-term androgen deprivation therapy (GETUG AFU 18): a randomised, phase 3 trial – The Lancet Oncology 

High-dose radiotherapy in patients with high-risk prostate cancers treated with long-term androgen deprivation therapy (GETUG AFU 18): a randomised, phase 3 trial